Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$3.01 - $4.81 $91,883 - $146,830
-30,526 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$3.36 - $5.34 $56,316 - $89,503
-16,761 Reduced 35.45%
30,526 $138,000
Q3 2021

Nov 12, 2021

BUY
$3.3 - $6.49 $156,047 - $306,892
47,287 New
47,287 $263,000
Q1 2021

May 13, 2021

SELL
$4.75 - $6.87 $139,787 - $202,177
-29,429 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$5.35 - $7.77 $157,445 - $228,663
29,429 New
29,429 $158,000
Q1 2020

May 08, 2020

SELL
$2.58 - $6.6 $32,882 - $84,117
-12,745 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$5.02 - $6.66 $63,979 - $84,881
12,745 New
12,745 $66,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $49.7M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.